glp-1 dementia study The EVOKE trials found that semaglutide, the drug behind several popular diabetes and weight loss medications, did not meaningfully slow cognitive decline in people with Alzheimer's disease. Despite these findings, scientists GLP-1 and Alzheimer's Disease: Research

The adrenal gland is under direct control of the pituitary gland deep in our brains

Certain peptides have potentially beneficial properties for the body

He serves on advisory boards and speakers panels of Novo Nordisk, Herbalife, GI Dynamics, Eli Lilly, Johnson & Johnson, Glia, Irish Life Health, Boehringer Ingelheim, Currax, Zealand Pharma, Keyron, and Rhythm Pharma

Undeclared pharmacologically active substances in illegal and falsified products can cause extreme harm to public health and pose a serious threat to human life

Each batch is third-party tested at 99.553% purity, with the Certificate of Analysis available in our CoA library